Initiator Pharma AS (OSTO:INIT) Cyclically Adjusted FCF per Share: kr-0.81 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:INIT Initiator Pharma AS OSTO:INIT
24 GF Score
Price kr2.27
! 1 Warning Sign
View Full Analysis

What is Initiator Pharma AS Cyclically Adjusted FCF per Share?

Initiator Pharma AS OSTO:INIT -0.87% 24 Cyclically Adjusted FCF per Share is kr-0.81 as of Mar. 2026. GuruFocus rates OSTO:INIT with a GF Score™ of 24/100. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Initiator Pharma AS's adjusted free cash flow per share for the three months ended in Mar. 2026 was kr-0.249. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is kr-0.81 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-28), Initiator Pharma AS's current stock price is kr2.27. Initiator Pharma AS's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was kr-0.81. Initiator Pharma AS's Cyclically Adjusted Price-to-FCF of today is .


Initiator Pharma AS  (OSTO:INIT) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Initiator Pharma AS Cyclically Adjusted FCF per Share Related Terms


Initiator Pharma AS Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Initiator Pharma AS's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Initiator Pharma AS Cyclically Adjusted FCF per Share Chart

Initiator Pharma AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Initiator Pharma AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.81

OSTO:INIT vs VRTX, REGN, RVMD: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Initiator Pharma AS's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Initiator Pharma AS Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Initiator Pharma AS's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Initiator Pharma AS's Cyclically Adjusted Price-to-FCF falls into.


OSTO:INIT
24GF Score
Initiator Pharma AS OSTO:INIT
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Initiator Pharma AS Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Initiator Pharma AS's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.249/121.6800*121.6800
=-0.249

Current CPI (Mar. 2026) = 121.6800.

Initiator Pharma AS Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.000 100.600 0.000
201609 -0.075 100.200 -0.091
201612 0.003 100.300 0.004
201703 -0.273 101.200 -0.328
201706 -0.157 101.200 -0.189
201709 -0.153 101.800 -0.183
201712 -0.438 101.300 -0.526
201803 -0.715 101.700 -0.855
201806 -0.302 102.300 -0.359
201809 -0.196 102.400 -0.233
201812 -0.046 102.100 -0.055
201903 -0.219 102.900 -0.259
201906 -0.105 102.900 -0.124
201909 -0.165 102.900 -0.195
201912 -0.120 102.900 -0.142
202003 -0.028 103.300 -0.033
202006 -0.038 103.200 -0.045
202009 -0.206 103.500 -0.242
202012 -0.093 103.400 -0.109
202103 -0.106 104.300 -0.124
202106 -0.084 105.000 -0.097
202109 -0.802 105.800 -0.922
202112 -0.266 106.600 -0.304
202203 -0.235 109.900 -0.260
202206 -0.256 113.600 -0.274
202209 -0.203 116.400 -0.212
202212 -0.198 115.900 -0.208
202303 -0.155 117.300 -0.161
202306 -0.215 116.400 -0.225
202309 -0.188 117.400 -0.195
202312 0.060 116.700 0.063
202403 -0.180 118.400 -0.185
202406 -0.113 118.500 -0.116
202409 -0.067 118.900 -0.069
202412 0.040 118.900 0.041
202503 -0.086 120.200 -0.087
202506 -0.215 120.700 -0.217
202509 -0.095 121.600 -0.095
202512 -0.051 121.200 -0.051
202603 -0.249 121.680 -0.249

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of kr-0.81 mean?
Initiator Pharma AS (OSTO:INIT) has a Cyclically Adjusted FCF per Share of kr-0.81 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Initiator Pharma AS and its competitors.
Is Initiator Pharma AS's Cyclically Adjusted FCF per Share too high?
Initiator Pharma AS's current Cyclically Adjusted FCF per Share is kr-0.81. Overall, Initiator Pharma AS has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Initiator Pharma AS's Cyclically Adjusted FCF per Share compare to VRTX and REGN?
Initiator Pharma AS's Cyclically Adjusted FCF per Share of kr-0.81 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Initiator Pharma AS and its competitors. Initiator Pharma AS's current Cyclically Adjusted FCF per Share is kr-0.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Initiator Pharma AS stock overvalued right now?
Initiator Pharma AS (OSTO:INIT) has a current Cyclically Adjusted FCF per Share of kr-0.81. The current Cyclically Adjusted FCF per Share is kr-0.81. Initiator Pharma AS's overall GF Score™ is 24/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Initiator Pharma AS (OSTO:INIT), the current Cyclically Adjusted FCF per Share is kr-0.81 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Initiator Pharma AS Business Description

Address Co/ COBIS, Ole Maaloesvej 3, Copenhagen, DNK, 2200
Initiator Pharma AS is a Danish clinical-stage life science company developing drugs that target key unmet medical needs within the central and peripheral nervous system. Its pipeline consists of three clinical programs: IP2018 and pudafensine for the treatment of erectile dysfunction of psychogenic and organic origin, respectively.
24GF Score

Get the complete analysis for OSTO:INIT

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.27
Price